Bio Solutions Aktie

Bio Solutions für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A0YE4N / ISIN: US09057D1046

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
27.08.2013 13:30:00

Bio-Solutions Corporation Announces Campaign on Lockerdome.com to Help Raise Money for the Benefit of Juvenile Diabetes

SAN ANTONIO, August 27, 2013 /PRNewswire/ --

Bio-Solutions Corporation (OTCQB: BISU) is pleased to announce that we have initiated a campaign on Lockerdome.com to help raise money for the benefit of Juvenile Diabetes. Lockerdome.com is the premier destination on the internet for both professional and amateur athletes. Monthly traffic to Lockerdome.com is in excess of 14 million visitors per month and Bio-Solutions is confident that it can reach athletes who have diabetes through Lockerdome.com and help them reach their training potential by using the company's product, Type 2 Defense.

The Bio-Solutions Corp. page on Lockerdome.com will allow young athletes with diabetes to interact with pro athletes with diabetes. This one on one interaction with the pros will show young diabetics that diabetes is not an obstacle to achieving greatness. The pro ranks are full of star athletes who have made it to the top without letting diabetes get in their way. We invite everyone who is interested to check out the page for news on product endorsers and product giveaways.

Every order that originates from the Lockerdome.com campaign, will result in a portion of net proceeds being donated to Juvenile Diabetes. Both Bio-Solutions Corp and Lockerdome.com support the activities of Juvenile Diabetes on a regional and national basis. We encourage everyone to visit the new Bio-Solutions Corp page on Lockerdome.com by clicking biosolutionscorp.lockerdome.com

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:   This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All   statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking   statements generally can be identified by phrases such as management "believes", "expects", "anticipates", "foresees", "forecasts", "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.  

CONTACT:
http://www.biosolutionscorp.com
Investor Relation Contact:
William Gallagher
Phone: +1-210-218-4475
email: info@biosolutionscorp.com

SOURCE Bio-Solutions Corp

Nachrichten zu Bio Solutions Corpmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Bio Solutions Corpmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!